
Orphan drugs will be a fifth of prescription drug sales by 2030
Orphan drugs will make up a fifth of the forecasted $1.6 trillion in worldwide prescription drug sales by 2030, according to Evaluate’s 2025 Orphan Drug Report. The 2025 report, based on Evaluate Pharma forecasts, projects that the segment will continue to outpace the… Read More














